Arcadia Biosciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $1,455 | $1,200 | $1,216 | $1,537 |
Gross Profit | 631 | 518 | 389 | 505 |
EBITDA | -5,975 | -1,207 | -2,258 | -1,753 |
EBIT | -5,990 | -1,220 | -2,279 | -1,760 |
Net Income | -4,458 | 2,599 | -4,064 | -1,612 |
Net Change In Cash | 1,455 | 1,200 | 1,216 | 1,537 |
Free Cash Flow | -2,033 | -1,588 | -2,209 | -1,752 |
Cash | 1,376 | 3,159 | 4,242 | 3,936 |
Basic Shares | 1,367 | 1,366 | 1,363 | 1,363 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $5,045 | $5,330 | $9,956 | $6,780 |
Gross Profit | 2,082 | 2,030 | 154 | -1,928 |
EBITDA | -7,499 | -13,578 | -13,647 | -23,267 |
EBIT | -7,612 | -13,865 | -15,010 | -24,312 |
Net Income | -7,038 | -13,981 | -15,612 | -16,134 |
Net Change In Cash | 5,045 | 5,330 | 9,956 | 6,780 |
Free Cash Flow | -9,643 | -15,299 | -14,049 | -26,875 |
Cash | 4,242 | 6,518 | 20,644 | 28,685 |
Basic Shares | 1,363 | 1,236 | 599 | 532 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$3.26 |
2025-03-31 | $1.90 |
2024-12-31 | -$2.99 |
2024-09-30 | -$0.87 |
